Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model
Authors:
- Rayhana Rahim-BataRRRayhana Rahim-Bata
- Andrew B. FreemanAFAndrew B. Freeman
- Charles D. ClarkeCCCharles D. Clarke
- Rachael L. HowardRHRachael L. Howard
- Jeannine S. StroblJSJeannine S. Strobl
- 1 November 2004
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (9) , 1729-1738
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The amino terminal and E2F interaction domains are critical for C/EBPα-mediated induction of granulopoietic development of hematopoietic cellsBlood, 2003
- pRB Contains an E2F1-Specific Binding Domain that Allows E2F1-Induced Apoptosis to Be Regulated Separately from Other E2F ActivitiesMolecular Cell, 2003
- E2F Modulates Keratinocyte Squamous DifferentiationJournal of Biological Chemistry, 2003
- Myc protein is differentially sensitive to quinidine in tumorversus immortalized breast epithelial cell linesInternational Journal of Cancer, 2002
- Retinoblastoma Protein Transcriptional Repression through Histone Deacetylation of a Single NucleosomeMolecular and Cellular Biology, 2002
- Sibling rivalry in the E2F familyNature Reviews Molecular Cell Biology, 2002
- Rapid Induction of Histone Hyperacetylation and Cellular Differentiation in Human Breast Tumor Cell Lines following Degradation of Histone Deacetylase-1Journal of Biological Chemistry, 2000
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylaseProceedings of the National Academy of Sciences, 1996
- Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nucleiNucleic Acids Research, 1983